Kiadis Pharma: Sanofi completes Kiadis acquisition
This is a joint press release by Sanofi Foreign Participations B.V. (the "Offeror"), Sanofi ("Sanofi") and Kiadis Pharma N.V. ("Kiadis"),View post on CompanyNewsHQ: Sanofi completes Kiadis acquisition
Read full article »
Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer.
Read more